Pernicious placenta previa and accrete left in situ: how to estimate and manage postpartum.

ZHANG Xue-mei; QI Hong-bo.

doi:10.7504/fk2014110102

PDF(950 KB)

Chinese Journal of Practical Gynecology and Obstetrics ›› 2014, Vol. 30 ›› Issue (12) : 918-921. DOI: 10.7504/fk2014110102

Pernicious placenta previa and accrete left in situ: how to estimate and manage postpartum.

ZHANG Xue-mei，QI Hong-bo.

Author information +

History +

Abstract

Abstract:Placenta left in situ is one of conservative management for placenta previa and accrete. It can reduce the rate of hysterectomy, transfusion and disseminated intravascular coagulation (DIC). It is an increasingly concerned problem that how the obstetricians decide to leave the placenta in situ and manage post-partum situation in time.

Key words

pernicious placenta previa / placenta accrete / placenta left in situ

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHANG Xue-mei，QI Hong-bo.. Pernicious placenta previa and accrete left in situ: how to estimate and manage postpartum.[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2014, 30(12): 918-921 https://doi.org/10.7504/fk2014110102

References

[1］ Chattopadhyay SK, Kharif H, Sherbeeni MM.Placenta praevia and accreta after previous caesarean section［J］.Eur J Obstet Gynecol Reprod Biol，1993，52(3):151-156.

[2］ Rosenberg T, Pariente G, Sergienko R,et al.Critical analysis of risk factors and outcome of placenta previa［J］.Arch Gynecol Obstet，2011，284:47-51.

[3］刘兴会，姚强. 凶险型前置胎盘的诊断和处理［J］.中国实用妇科与产科杂志, 2011,27(2):85-89.

[4］ Sentilhes L, Goffinet F, Kayem G. Management of placenta accrete［J］. Acta Obstet Gynecol Scand，2013，92(10):1125-1134.

[5］ Kayem G, Davy C, Goffinet F,et al. Conservative versus extirpative management in cases of placenta accreta［J］. Obstet Gynecol，2004 ,104(3):531-536.

[6］ Aggarwal R,Suneja A,Vaid NB,et al. Morbidly adherent placenta: a critical review［J］. J Obstet Gynaecol India, 2012,62(1):57-61.

[7］ Hequet D, Morel O, Soyer P,et al. Delayed hysteroscopic resection of retained tissues and uterine conservation after conservative treatment for placenta accrete［J］. Aust N Z J Obstet Gynaecol,2013，53(6):580-583.

[8］ ACOG.Committee opinion no. 529: placenta accreta［J］.Obstet Gynecol，2012 ，120(1):207-211.

[9］应豪, 王德芬. 植入性胎盘的保守治疗［J］.实用妇产科杂志, 2008, 24(12) : 710-712 .

[10］ Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids［J］.Fertil Steril, 2006, 85(1):22-29.

[11］ Wu F, Wang ZB, Chen WZ, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of patients with large hepatocellular carcinoma［J］. Ann Surg Oncol, 2004, 12:1061-1069.

[12］付晓敏，罗欣，漆洪波. 高强度聚焦超声治疗产后胎盘植入22例临床研究［J］.中国实用妇科与产科杂志,2013,29(8)：649-652.

[13］ Zhang X, Zheng Y, Wang Z,et al.Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and synergistic targeted therapy of residual tumor during HIFU ablation［J］. Biomaterials,2014,35:5148-5161.

[14］ Yu T, Xu C. Hyperecho as the indicator of tissue necrosis during microbubble-assisted high intensity focused ultrasound: sensitivity, specificity and predictive value［J］.Ultrasound Med Biol,2008, 34(8):1343-1347.

[15］何梦舟,邓东锐. 胎盘植入患者胎盘原位保留治疗［J］. 中华产科急救电子杂志,2014, 3(1): 21-26.

[16］ Kayem G, Anselem O, Schmitz T,et al. Conservative versus radical management in cases of placenta accreta: a historical study［J］. J Gynecol Obstet Biol Reprod (Paris),2007,36(7):680-687.